Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for DeliverySpyros A. Kalams, John Hural, Stephen De Rosa et al.|The Journal of Infectious Diseases|2013Cited by 197
Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like ParticlesPaul Goepfert, Harriet L. Robinson, Marnie Elizaga et al.|The Journal of Infectious Diseases|2011Cited by 177
Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected AdultsSpyros A. Kalams, Scott Parker, Xia Jin et al.|PLoS ONE|2012Cited by 111
Timing of Plasmid Cytokine (IL-2/Ig) Administration Affects HIV-1 Vaccine Immunogenicity in HIV-Seronegative SubjectsLindsey R. Baden, William A. Blattner, Cecilia Morgan et al.|The Journal of Infectious Diseases|2011Cited by 25